Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06006819

Prognostic Markers of Acute Heart Failure With Chronic Kidney Disease

Sponsor: Cheng-Hsin General Hospital

View on ClinicalTrials.gov

Summary

Acute heart failure (AHF) is defined as new or worsening of symptoms and signs of heart failure and is the most frequent cause of unplanned hospital admission in elderly patients. N-terminal pro-brain natriuretic peptide (NT-pro-BNP) is one of the most developed prognostic markers for AHR patients and. NT-pro-BNP has limitations in terms of diagnostic or predictive accuracy in patients with chronic kidney disease (CKD). Plasma proteomics have the potential to examine underlying pathophysiological and prognostic roles, so we compared the plasma proteomic signature to predict outcomes of patients with or without CKD hospitalized for AHF.

Official title: Plasma Proteomic Signature and the Prognosis of Acute Heart Failure With or Without Chronic Kidney Disease

Key Details

Gender

All

Age Range

20 Years - 90 Years

Study Type

OBSERVATIONAL

Enrollment

155

Start Date

2023-01-01

Completion Date

2025-12-23

Last Updated

2024-08-23

Healthy Volunteers

No

Locations (1)

Cheng Hsin General Hospital

Taipei, Baitou District, Taiwan